CNTB Connect Biopharma Holdings Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: CNTB

Price (delayed)

$1.07

Market cap

$67.38M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.19

Enterprise value

$40.96M

?
Relative Growth: Rel. Growth: 31
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 5
Relative Profitability: Rel. Profitability: 20
Highlights
The company's gross profit has surged by 50% YoY
Connect Biopharma Holdings's revenue has soared by 50% YoY
The quick ratio has shrunk by 68% YoY and by 22% QoQ
The equity has plunged by 62% YoY and by 37% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.connectbiopharm.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of CNTB

CNTB stock price

How has the Connect Biopharma Holdings stock price performed over time
Intraday
-11.93%
1 week
-13.71%
1 month
-54.66%
1 year
-33.99%
YTD
-62.06%
QTD
-55.04%

Financial performance

How have Connect Biopharma Holdings's revenue and profit performed over time
Revenue
$2.95M
Gross profit
$2.95M
Operating income
-$70.41M
Net income
-$68.99M
Gross margin
100%
Net margin
-2,336.3%
The operating margin has soared by 92% from the previous quarter and by 3.1% YoY
Connect Biopharma Holdings's net margin has surged by 92% QoQ but it has decreased by 2.1% YoY
The net income has dropped by 53% year-on-year and by 7% since the previous quarter
The company's gross profit has surged by 50% YoY

Price vs fundamentals

How does CNTB's price correlate with its fundamentals

Growth

What is Connect Biopharma Holdings's growth rate over time

Valuation

What is Connect Biopharma Holdings stock price valuation
P/E
N/A
P/B
2.51
P/S
22.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.87
The EPS has contracted by 47% YoY and by 3.5% from the previous quarter
The equity has plunged by 62% YoY and by 37% from the previous quarter
The price to book (P/B) is 21% lower than the last 4 quarters average of 3.6
The price to sales (P/S) is 97% lower than the last 4 quarters average of 812.4
Connect Biopharma Holdings's revenue has soared by 50% YoY

Efficiency

How efficient is Connect Biopharma Holdings business performance
The company's return on assets has shrunk by 175% YoY and by 25% QoQ
CNTB's return on invested capital has dropped by 160% since the previous quarter
The ROS has soared by 92% from the previous quarter but it has contracted by 2.5% YoY
Connect Biopharma Holdings's ROE has decreased by 35% from the previous quarter

Dividends

What is CNTB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CNTB.

Financial health

How did Connect Biopharma Holdings financials performed over time
The total assets is 162% more than the total liabilities
The quick ratio has shrunk by 68% YoY and by 22% QoQ
The current ratio has plunged by 67% YoY and by 27% from the previous quarter
Connect Biopharma Holdings's debt is 98% lower than its equity
Connect Biopharma Holdings's debt to equity has soared by 100% YoY
The equity has plunged by 62% YoY and by 37% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.